Latest Risk Assessments |
 |
Multi-country outbreak of Salmonella Mbandaka ST413 possibly linked to consumption of chicken meat in the EU/EEA, Israel and the UKDate of publication: 30 November 2022 A cross-border outbreak of Salmonella Mbandaka ST413 has been ongoing in the EU/EEA, Israel, and the UK since September 2021. Available from the ECDC website |
 |
Risk of Sudan virus to EU/EEA citizens considered very lowDate of publication: 9 November 2022 In this Rapid Risk Assessment, ECDC assesses the risk of Ebola disease caused by Sudan virus, which is one of the human ebolaviruses, as very low to citizens in the EU/EEA. Available from the ECDC website |
|
Monitoring |
 |
Assessing the health burden of infections with antibiotic-resistant bacteria in the EU/EEA, 2016-2020Date of publication: 17 November 2022 This report aims to provide updated estimates of the burden of infections with selected bacterium–antibiotic resistance combinations in the EU/EEA in 2016-2020 and assess how this burden has changed from previous estimates. Available from the ECDC website |
 |
Surveillance of antimicrobial resistance in Europe, 2021 dataDate of publication: 17 November 2022 This executive summary is based on antimicrobial resistance (AMR) data from invasive isolates reported to the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) network and the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2022 (data referring to 2021). Available from the ECDC website |
 |
Joint report with the WHO Regional Office for Europe on HIV/AIDS surveillance – 2021 dataDate of publication: 30 November 2 This report is the latest in a series published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been reporting data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007. Available from the ECDC website |
|
 |
Continuum of HIV care – Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2021 progress reportDate of publication: 30 November 2022 By 2021, 48 of 55 countries in Europe and Central Asia provided data on at least one stage of the continuum of HIV care (compared to 40 countries in 2018). A total of 47 countries were able to provide data for at least two consecutive stages of the continuum (compared to 45 in 2020) and 40 countries provided data on all four stages. Available from the ECDC website |
|
 |
Summary of Expert Panel meeting discussions on interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugsDate of publication: 22 November 2022 This report documents the process and outcome of the assessment and translation of the evidence into guidance recommendations on linkage to care and/or adherence to treatment for HCV, HIV and TB for the below systematic literature review. Available from the ECDC website |
|
 |
A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugsDate of publication: 22 November 2022 The purpose of this review was to identify and synthesise the existing evidence on effectiveness of interventions targeting people who inject drugs at two stages of the care cascade: linkage to care and adherence to treatment of HIV, hepatitis B/C and TB. Available from the ECDC website |
|
 |
Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to SARS-CoV-2 in individuals aged 20 years and older – third updateDate of publication: 8 November 2022 This update reports on one of the ECDC multi-country studies assessing vaccine effectiveness against severe acute respiratory infection (SARI) due to laboratory-confirmed SARS-CoV-2 in the hospital setting. Available from the ECDC website |
|
 |
Interim analysis of COVID-19 vaccine effectiveness in healthcare workers, an ECDC multi-country study, May 2021–July 2022Date of publication: 21 November 2022 This document reports on one of ECDC’s multi-country studies in the hospital setting to measure product-specific COVID-19 VE against any laboratory-confirmed SARS-CoV-2 infection among healthcare workers (HCWs) eligible for vaccination. Available from the ECDC website |
|
|
|
Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts, version 2.0Date of publication: 21 November 2022 This generic protocol for ECDC studies describes the design and methods for a prospective multi-country cohort study of hospital-based healthcare workers (HCWs) to evaluate the effectiveness of COVID-19 vaccine in preventing laboratory-confirmed SARS-CoV-2 infection. Available from the ECDC website |
|
|
|
Use and impact of new technologies for evidence synthesis – Literature review and qualitative data collectionDate of publication: 18 November 2022 This report studies the implementation and impact of new technologies to support the development of evidence syntheses. Available from the ECDC website |
|
|
|
Influenza virus characterisation – September 2022Date of publication: 5 October 2022 This is the ninth and final report for the 2021-2022 influenza season. As of week 39/2022, 149 372 detections had been reported, resulting from extended late season influenza activity. Available from the ECDC website |
|
|
|
Annual Epidemiological Report series on communicable diseases in Europe
|
|
|
|
ECDC communicable disease threats reportDate of publication: every Friday The ECDC communicable disease threats report is a weekly bulletin intended for epidemiologists and health professionals in the area of communicable disease prevention and control. Summarising information gathered by ECDC through its epidemic intelligence activities regarding communicable disease threats of concern to the European Union, it also provides updates on the global situation and changes in the epidemiology of communicable diseases with potential to affect Europe, including diseases that are the focus of eradication efforts. Available from the ECDC website |
|
Scientific peer-reviewed publications |
||
|
|
Publications by ECDC staff in scientific journalsAll scientific peer-reviewed publications produced by ECDC staff on behalf of the Centre for the period January 2005 – December 2021 are available online. Available from the ECDC website |
|
